series-a
Stage
3
Investors
About
Muna Therapeutics develops novel cell therapies targeting innate-like T cells for the treatment of solid tumors and autoimmune diseases.
Explore Muna Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.